Tarsus Pharmaceuticals, Inc. TARS Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Tarsus Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:CommonStockSharesAuthorized.
The official record: Tarsus Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tarsus Pharmaceuticals, Inc.'s common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tarsus Pharmaceuticals, Inc.'s common stock?
- Tarsus Pharmaceuticals, Inc. (TARS) reported common stock of 200M in Q1 2026.
- How has Tarsus Pharmaceuticals, Inc.'s common stock changed year-over-year?
- Tarsus Pharmaceuticals, Inc.'s common stock decreased by 0.0% year-over-year, from 200M to 200M.
- What is the long-term trend for Tarsus Pharmaceuticals, Inc.'s common stock?
- Over 5 years (2020 to 2025), Tarsus Pharmaceuticals, Inc.'s common stock has grown at a 0.0% compound annual growth rate (CAGR), from 200M to 200M.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).